The company’s upcoming earnings report date is not yet available.
Is Halberd overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Halberd pay dividends?
Halberd does not currently pay dividends.
What is Halberd’s EPS estimate?
Halberd’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Halberd have?
Halberd has 515,874,800 shares outstanding.
Which hedge fund is a major shareholder of Halberd?
Currently, no hedge funds are holding shares in HALB
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Halberd
Halberd Corporation is a biotechnology firm dedicated to pioneering therapies for neurodegenerative conditions. The company's therapeutic focus encompasses a broad range of serious illnesses, including post-traumatic stress disorder (PTSD) and chronic traumatic encephalopathy (CTE), Alzheimer's disease, Parkinson's disease, various forms of cancer, and disorders impacting the blood and cerebrospinal fluid. Established in 2009, Halberd Corporation operates from its headquarters in Jackson Center, Pennsylvania.